Results 231 to 240 of about 551,136 (353)

Obstetrics and Gynecology [PDF]

, 2012
中島 彰俊, 伊藤 実香, 塩崎 有宏, 山中 美樹子, 島 友子, 日高 隆雄, 米田 哲, 米田 徳子, 長谷川 徹, 齋藤 滋   +9 more
core   +1 more source

HIF2A as a prognostic and clinical therapeutic target in ovarian clear cell carcinoma

International Journal of Cancer, EarlyView.
What's New? Ovarian clear cell carcinoma is highly associated with hypoxia. Hypoxia‐inducible factor 2A (HIF2A) is a key regulator of hypoxic responses, but its role in ovarian clear cell carcinoma remains unclear. This study demonstrated the unfavorable prognostic significance of HIF2A expression in ovarian clear cell carcinoma.
Mengxin Jiang, Ken Yamaguchi, Kohei Hamada, Yuko Hosoe, Yuka Mise, Sachiko Kitamura, Zhihong Liu, Hairong Wei, Zhenhai Gao, Mana Taki, Koji Yamanoi, Ryusuke Murakami, Rin Mizuno, Taito Miyamoto, Junzo Hamanishi, Masaki Mandai   +15 more
wiley   +1 more source

Status quo and future directions of digitalization in gynecology and obstetrics in Germany: a survey of the commission Digital Medicine of the German Society for Gynecology and Obstetrics. [PDF]

Arch Gynecol Obstet
Pfob A, Hillen C, Seitz K, Griewing S, Becker S, Bayer C, Wagner U, Fasching P, Wallwiener M, Kommission Digitale Medizin, Deutsche Gesellschaft für Gynäkologie und Gebursthilfe (DGGG).   +10 more
europepmc   +1 more source

Cost‐effectiveness analysis of human papillomavirus (HPV) genotyping strategies for management of HPV‐positive women in cervical cancer screening

International Journal of Cancer, EarlyView.
What's New? Persistent infection with high‐risk human papillomavirus (HPV) causes most invasive cervical cancer cases, leading many countries to transition from cytology to primary HPV‐based screening. Despite the benefits, HPV‐based screening may also lead to unnecessary procedures, psychological burden, and strain on healthcare systems.
Kelsi R. Kroon, Johannes A. Bogaards, Johannes Berkhof   +2 more
wiley   +1 more source

Revisiting the evolution of the Hippocratic Oath in obstetrics and gynecology [PDF]

Anthony M. Vintzileos, Ioannis Mylonas
openalex   +1 more source

The cervico‐vaginal DNA methylation WID‐qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancer

International Journal of Cancer, EarlyView.
What's New? The DNA methylation‐based WID‐qEC test has been validated for the accurate detection of endometrial and cervical cancers using cervico‐vaginal samples. However, a small proportion of women test positive despite the absence of these cancers. This study explored the associated biological and clinical characteristics to inform potential follow‐
Elisa Redl, Chiara Herzog, Charlotte Vavourakis, James Barrett, Allison Jones, Iona Evans, Daniel Reisel, Ranjit Manchanda, Line Bjørge, Michal Zikan, David Cibula, Twana Alkasalias, Angelique Flöter Rådestad, Kristina Gemzell‐Danielsson, Louis Dubeau, Nicola MacDonald, Davor Jurkovic, Nora Pashayan, Martin Widschwendter   +18 more
wiley   +1 more source

Dedicated to Gynecology and Obstetrics

Acta Médica del Centro, 2011
José Antonio Gonzáles Acosta, Georgina Díaz Serrano   +1 more
doaj  

Lymphadenectomy and chemotherapy are effective treatments for patients with 2023 international federation of gynecology and obstetrics stage IIC-high risk endometrial cancer in Japan. [PDF]

Int J Clin Oncol
Tani Y, Nakamura K, Yorimitsu M, Seki N, Nakanishi M, Itou H, Shimizu M, Yamamoto D, Takahara E, Masuyama H.   +9 more
europepmc   +1 more source

Cell-free fetal DNA: the new tool in fetal medicine. [PDF]

, 2014
Chitty, LS, Everett, TR
core   +1 more source

Corrigendum to “Obstetric fistulas: A clinical review” [International Journal of Gynecology and Obstetrics (2007) 99:S40–S46] [PDF]

, 2009
Andreea A. Creanga, Rene R. Genadry
openalex   +1 more source